Author:
Bokemeyer C,Kollmannsberger C,Stenning S,Hartmann J T,Horwich A,Clemm C,Gerl A,Meisner C,Rückerl C-P,Schmoll H-J,Kanz L,Oliver T
Publisher
Springer Science and Business Media LLC
Reference15 articles.
1. Bajorin DF, Sarosdy MF, Pfister DG, Mazumdar M, Motzer RJ, Scher HI, Geller NL, Fair WR, Herr H, Sogani P (1993) Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: a multiinstitutional study. J Clin Oncol 11: 598–606
2. Bokemeyer C, Kohrmann O, Tischler J, Weissbach L, Rath U, Haupt A, Schoffski P, Harstrick A, Schmoll HJ (1996) A randomized trial of cisplatin, etoposide and bleomycin (PEB) versus carboplatin, etoposide and bleomycin (CEB) for patients with ‘good-risk’ metastatic non-seminomatous germ cell tumors. Ann Oncol 7: 1015–1021
3. Bosl GJ, Motzer RJ (1997) Medical progress: testicular germ-cell cancer. N Engl J Med 337: 242–253
4. Clemm C, Bokemeyer C, Gerl A, Holzel D, Weissbach L, Bamberg M, Schoeffski P, Harstrick A, Schmoll HJ, Wilmanns W (2000) Randomized trial comparing cisplatin/etoposide/ifosfamide with carboplatin monochemotherapy in patients with advanced metastatic seminoma. Proc Am Soc Clin Oncol 19: 328 (abstract 1283)
5. Clemm C, Gerl A, Kohl P, Hentrich M, Hartenstein R, Gassel WD, Knutzen B, Wilmanns W (1993) Combination chemotherapy containing cisplatin/ifosfamide and vinblastine or etoposide in bulky seminoma. Eur J Cancer 29A (Suppl 6): S240 (abstract 1347)
Cited by
83 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献